President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members participating in the action.

The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the agency left the case in limbo.

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

This week, the Federal Trade Commission halted its lawsuit against pharmacy-benefit managers CVS Caremark (CVS), Express Scripts (CI), and ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after President Trump fired two of the agency’s commissioners.

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...

The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and CVS Health over insulin prices after the Trump administration fired two of ...

The FTC chair had previously been recused from the lawsuit. But after consulting with ... the FTC’s general counsel elected to pause it. Ferguson’s decision to return to the case now allows ...

Andrew Ferguson, the chair of the Federal Trade Commission, has decided to rejoin the agency’s lawsuit against ... drug middlemen. The FTC paused the litigation against CVS’ Caremark, Cigna ...